NCT05586841 2026-05-29Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase â… b StudyBeijing 302 HospitalPhase 1 Completed22 enrolled